Glenn Kerkhof is the Interim Chief Executive Officer of Emerald Clinical. Glenn has over 30 years’ experience in the pharmaceutical services industry and joined from Chiltern, where he was Chief Executive Officer, based in London. Before Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories, and as Vice President, Clinical Europe for Inveresk Research. He is a Non-Executive Director of Infensa Biosciences, and his previous directorships include Cell Care Pty. Ltd. Glenn, based in Melbourne, works closely with the executive team to formulate and execute Emerald Clinical’s global strategy.